source
- Novo Nordisk invests $380M to expand manufacturing in Czech Republic and China, while Cellares raises $50M Series DNovo Nordisk announced a significant investment to broaden its manufacturing footprint in both China and the Czech Republic. In the Czech Republic, the company is allocating roughly $380 million t…
- CMS recalculates 2026 Medicare Advantage star ratings, increasing program volatility and affecting $16 billion in bonusesFederal officials have issued a new memo that recalculates the quality ratings for 2026 Medicare Advantage plans. The change follows another lawsuit from insurers that contest lower star ratings,…